RAPITHER-AB
Brand:
RAPITHER-AB
Manufacturer:
IPCA
Manufacturer Details
IPCA
Compositions:
Arteether 75mg/ml/150mg/ml injection,
|
Strength
|
Rate
|
Packing Style
|
|
75mg/ml inj
|
61.60
|
1 ml amp injection
|
|
75mg/ml in
|
78.00
|
2ml amp injection
|
|
150mg/ml
|
94.35
|
2ml injection
|
List of Related Indications:
List Of Drugs:
- Arteether - Antimalarials
Indication Type Description:
Drug Interaction:
Avoid using with drugs that prolong QT interval
Indication:
Malaria
LIST OF DRUGS DURING 2004
Sr.No- 237
Name of the Drug- b-Arteether injection 9150mg/2ml)
Pharmacological Classification- Anti-malaria
Date of Approval- 01-09-2004
Approved by U.S.FDA on 30-12-2004 (Ref- FDA approved List- 2004)
Approved by (DCI) Drug Controller GENERAL - India For Marketting
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Arteether Anti-malarial 14-01-1997
2. B- Arteether injection 250mg/2ml 01-09-2004
Anti-malaria
Adverse Reaction:
Headache
Nausea,
Cough
Dizziness
Body ache and general weakness
Vomiting
Pain at inj site
Abdominal pain, leg pain
Chills andrigors
Watery diarrhea
Dosages/ Overdosage Etc:
Indication-
Malaria
Dosage-
Adult- 150mg daily for 3 consecutive days
